We are live on ! Find out more
MGNX icon

MacroGenics

130 hedge funds and large institutions have $796M invested in MacroGenics in 2019 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 56 increasing their positions, 38 reducing their positions, and 39 closing their positions.

New
Increased
Maintained
Reduced
Closed

176% more call options, than puts

Call options by funds: $4.98M | Put options by funds: $1.81M

161% more capital inflows, than outflows

Capital inflows: $305M | Capital outflows: $117M

47% more repeat investments, than reductions

Existing positions increased: 56 | Existing positions reduced: 38

5.41% more ownership

Funds ownership: 90.67% → 96.08% (+5.4%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

17% less funds holding

Funds holding: 157 → 130 (-27)

59% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 39

Holders
130
Holders Change
-27
Holders Change %
-17.2%
% of All Funds
2.81%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
16
Increased
56
Reduced
38
Closed
39
Calls
$4.98​M
Puts
$1.81​M
Net Calls
+$3.18​M
Net Calls Change
-⁠$1.56​M

MGNX Hedge Fund Activity: Q2 2019 in Review

130 of the 4,627 institutional investors tracked by Wall St. Rank reported a position in MacroGenics (MGNX) for Q2 2019, worth a combined $796M — down 0.04% from $796M a quarter earlier.

Sellers outnumbered buyers: 39 funds closed out of MGNX and 16 opened new positions — a net loss of 23 holders — while 38 trimmed existing stakes and 56 added.

The largest buyer was Invesco, adding an estimated $76.7M. The largest seller was Point72 Asset Management, cutting an estimated $19M.

  • 130 institutional investors held MacroGenics (MGNX) as of Q2 2019, down from 157 in Q1 2019.
  • Funds reported $796M of MacroGenics stock for Q2 2019, down 0.04% quarter-over-quarter.
  • 16 funds opened new MacroGenics positions in Q2 2019 and 39 closed out, a net change of -23 holders.
  • The largest MacroGenics buyer in Q2 2019 was Invesco, an estimated $76.7M added.
  • The largest MacroGenics seller in Q2 2019 was Point72 Asset Management, an estimated $19M sold.

Based on aggregated 13F filings for Q2 2019.